Related Experiment Videos

Growth failure, risk of hospitalization and death for children with end-stage renal disease

Susan L Furth1, Wenke Hwang, Ching Yang

  • 1Department of Pediatrics, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA. sfurth@jhmi.edu

Insights

Growth failure in children with kidney disease significantly increases hospitalization and mortality risks. Early identification and intervention are crucial for improving outcomes in pediatric end-stage renal disease patients.

Area of Science:

  • Pediatric Nephrology
  • Growth and Development
  • Chronic Kidney Disease

Background:

  • Growth failure is a prevalent complication in children with chronic renal insufficiency and end-stage renal disease (ESRD).
  • The clinical significance of growth failure in pediatric ESRD patients, particularly concerning hospitalization and mortality, requires further investigation.

Purpose of the Study:

  • To determine the association between growth failure and hospitalization rates in pediatric patients with end-stage renal disease (ESRD).
  • To assess the impact of growth failure on long-term survival in children with kidney failure.
  • To analyze the causes of death in relation to growth failure severity in pediatric ESRD.

Main Methods:

  • Retrospective cohort study of 1,112 prevalent US pediatric ESRD patients (dialysis and transplant) from 1990-1995.
  • Patients categorized by growth failure severity (severe, moderate, normal) using standard deviation scores (SDS).
  • Statistical analyses included relative risk, Kaplan-Meier survival analysis, and Cox proportional hazards modeling.

Main Results:

  • Patients with severe and moderate growth failure exhibited significantly higher hospitalization rates compared to those with normal growth.
  • Five-year survival rates were lower for children with severe (85%) and moderate (90%) growth failure versus normal growth (96%).
  • Severe and moderate growth failure were independently associated with increased mortality risk (RR 2.9 and 2.01, respectively).
  • Infectious causes of death were more frequent in children with growth failure.

Conclusions:

  • Growth failure in pediatric ESRD is linked to a more complex clinical course, characterized by increased hospitalizations and a higher risk of mortality.
  • These findings underscore the importance of monitoring and addressing growth in children with kidney failure to improve their overall prognosis.
  • Infectious complications may play a significant role in the increased mortality observed in this vulnerable population.

Related Concept Videos

Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...